We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microarray Products for Far East Market

By Labmedica staff writers
Posted on 12 Mar 2006
According to a new agreement, SciGene (Sunnyvale, CA, USA) has given ScienceWerke (Singapore) exclusive rights to market and support SciGene's microarray products in Singapore and Malaysia.

SciGene produces instruments using process control, automation, and protocol optimization to reduce microarray data errors, enabling users to quickly obtain reliable results. ScienceWerke focuses on novel and emerging technologies in the genomics and proteomics market segments.

Under the agreement, ScienceWerke will be supplying its customers in Singapore and Malaysia with SciGene's newest products for the microarray laboratory. These will include the Hybex microarray incubation system and the Little Dipper microarray processor. ScienceWerke envisages immediate acceptance of the BriteSpot microarray workstation by the microarray community there.

The president of SciGene, Dr. Jim Stanchfield, said that his company is fortunate to have found ScienceWerke, "A unique company that really understand the needs of the microarray laboratory, which can give high-quality technical support in a growing market.”





Related Links:
SciGene
ScienceWerke

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Tabletop Centrifuge
Mikro 185
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests